Indonesian Antitrust Regulator Fines Pfizer Units $14M

Law360, New York (September 28, 2010, 2:18 PM EDT) -- Indonesia's antitrust agency KPPU has fined Pfizer Inc. and four subsidiaries a total of about $14 million for violating the country's anti-monopoly statutes by abusing its dominant position in the market for anti-hypertensive drugs to overcharge consumers.

The agency said Tuesday that it had imposed a fine of of 25 billion Indonesian rupiah ($2.8 million) each on Pfizer and subsidiaries PT Pfizer Indonesia, Pfizer Overseas LLC, Pfizer Global Trading and Pfizer Corporation Panama for alleged anti-competitive conduct related to the blood pressure medication amlodipine, which the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.